NCI-H596 Cells

The NCI-H596 cell line is derived from a human adenosquamous carcinoma of the lung. This unique cell line is used extensively in lung cancer research, providing a model to study the characteristics and behavior of adenosquamous carcinoma, a rare subtype of non-small cell lung cancer that exhibits features of both adenocarcinoma and squamous cell carcinoma. The NCI-H596 cell line is valuable for investigating the molecular and genetic underpinnings of this hybrid cancer type, as well as for testing potential therapeutic interventions.
NCI-H596 cells exhibit an epithelial morphology and express markers indicative of both adenocarcinoma and squamous cell carcinoma, including cytokeratins and mucin proteins. They harbor genetic alterations common in lung cancer, such as mutations in the KRAS and TP53 genes, which are pivotal in cell signaling, growth, and apoptosis. Researchers utilize NCI-H596 cells to explore the signaling pathways involved in tumor progression, such as the EGFR, MAPK, and PI3K/Akt pathways. These cells are also employed in drug discovery and development, allowing for the evaluation of chemotherapeutic agents, targeted therapies, and novel treatment combinations. The NCI-H596 cell line’s dual histological features make it a critical tool for understanding the complexities of adenosquamous carcinoma and for advancing therapeutic strategies in lung cancer treatment.